Peifen Cai

681 total citations
11 papers, 566 citations indexed

About

Peifen Cai is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Peifen Cai has authored 11 papers receiving a total of 566 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Immunology. Recurrent topics in Peifen Cai's work include Immune cells in cancer (3 papers), Andrographolide Research and Applications (2 papers) and Histone Deacetylase Inhibitors Research (2 papers). Peifen Cai is often cited by papers focused on Immune cells in cancer (3 papers), Andrographolide Research and Applications (2 papers) and Histone Deacetylase Inhibitors Research (2 papers). Peifen Cai collaborates with scholars based in China, Czechia and United States. Peifen Cai's co-authors include Yanhong Gu, Qiang Xu, Yang Sun, Wenjie Guo, Lele Guo, Xuefeng Wu, Yan Shen, Yongqian Shu, Xingxin Wu and Xudong Wu and has published in prestigious journals such as Journal of Clinical Oncology, Toxicology and Applied Pharmacology and Autophagy.

In The Last Decade

Peifen Cai

11 papers receiving 560 citations

Peers

Countries citing papers authored by Peifen Cai

Since Specialization

Citations

This map shows the geographic impact of Peifen Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peifen Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peifen Cai more than expected).

Fields of papers citing papers by Peifen Cai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peifen Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peifen Cai. The network helps show where Peifen Cai may publish in the future.

Co-authorship network of co-authors of Peifen Cai

This figure shows the co-authorship network connecting the top 25 collaborators of Peifen Cai. A scholar is included among the top collaborators of Peifen Cai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peifen Cai. Peifen Cai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	Inhibition of NLRP3 inflammasome activation in myeloid-derived suppressor cells by andrographolide sulfonate contributes to 5-FU sensitization in mice 2021 ·Toxicology and Applied Pharmacology ·Lingyan Xu, Peifen Cai, Xiaofei Li, Xiaohan Wu, Jian Gao, Wen Liu, Jia‐Shu Yang, Qiang Xu, Wenjie Guo, Yanhong Gu	16
2	An open-label, randomized, controlled clinical trial to explore the curative effects between the treatment of capecitabine and andrographolide and the single capecitabine in the patients with pathological and/or histologic diagnosed unresectable, advanced, recurrent, and metastatic colorectal cancer. 2017 ·Journal of Clinical Oncology ·Yongqian Shu, Jing Sun, Peifen Cai, Weicheng Wang, Han Xiao, Yanhong Gu	9
3	Transmembrane-Bound IL-15–Promoted Epithelial-Mesenchymal Transition in Renal Cancer Cells Requires the Src-Dependent Akt/GSK-3β/β-Catenin Pathway 2015 ·Neoplasia ·(unknown), Xiaoxin Meng, Wenjie Guo, Peifen Cai, Wanshuai Li, Qian Li, Weicheng Wang, Yang Sun, Qiang Xu, Yanhong Gu	29
4	Novel role of Sarco/endoplasmic reticulum calcium ATPase 2 in development of colorectal cancer and its regulation by F36, a curcumin analog 2014 ·Biomedicine & Pharmacotherapy ·Lu Fan, Ang Li, Wanshuai Li, Peifen Cai, (unknown), Minxia Zhang, Yanhong Gu, Yongqian Shu, Yang Sun, Yan Shen, Xuefeng Wu, Gang Hu, (unknown), Qiang Xu	50
5	Axitinib augments antitumor activity in renal cell carcinoma via STAT3-dependent reversal of myeloid-derived suppressor cell accumulation 2014 ·Biomedicine & Pharmacotherapy ·(unknown), Peifen Cai, Qian Li, Weicheng Wang, Yang Sun, Qiang Xu, Yanhong Gu	51
6	Andrographolide sulfonate ameliorates experimental colitis in mice by inhibiting Th1/Th17 response 2014 ·International Immunopharmacology ·Wen Liu, Wenjie Guo, Lele Guo, Yanhong Gu, Peifen Cai, Ning Xie, Xiaoling Yang, Yongqian Shu, Xuefeng Wu, Yang Sun, Qiang Xu	77
7	Small molecule-driven mitophagy-mediated NLRP3 inflammasome inhibition is responsible for the prevention of colitis-associated cancer 2014 ·Autophagy ·Wenjie Guo, Yang Sun, Wen Liu, Xingxin Wu, Lele Guo, Peifen Cai, Xuefeng Wu, Xudong Wu, Yan Shen, Yongqian Shu, Yanhong Gu, Qiang Xu	243
8	Icotinib, a potent and specific EGFR tyrosine kinase inhibitor, inhibits growth of squamous cell carcinoma cell line A431 through negatively regulating AKT signaling 2013 ·Biomedicine & Pharmacotherapy ·Zhenzhen Gao, Wei Chen, Xiaohua Zhang, Peifen Cai, Xianying Fang, Qiang Xu, Yang Sun, Yanhong Gu	21
9	Axitinib, a selective inhibitor of vascular endothelial growth factor receptor, exerts an anticancer effect in melanoma through promoting antitumor immunity 2013 ·Anti-Cancer Drugs ·Xiaohua Zhang, Xianying Fang, Zhenzhen Gao, Wei Chen, Feifei Tao, Peifen Cai, (unknown), Yongqian Shu, Qiang Xu, Yang Sun, Yanhong Gu	27
10	Expression and clinical significance of tyrosine phosphatase SHP-2 in colon cancer 2013 ·Biomedicine & Pharmacotherapy ·Peifen Cai, Wenjie Guo, (unknown), Qian Li, Weicheng Wang, Yang Sun, Xiaomin Li, (unknown)	32
11	Efficacy of combined axitinib with dacarbazine in a B16F1 melanoma xenograft model 2013 ·Oncology Letters ·Xiaohua Zhang, Enqi Qiao, Zhenzhen Gao, (unknown), Peifen Cai, (unknown), (unknown)	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact